" /> Autologous Anti-BCMA CAR T-cells UF-KURE-BCMA - CISMeF





Preferred Label : Autologous Anti-BCMA CAR T-cells UF-KURE-BCMA;

NCIt synonyms : Autologous Anti-BCMA CAR-expressing CD4 /CD8 T-lymphocytes UF-KURE-BCMA; Autologous Anti-BCMA CAR T Cells UF-KURE-BCMA; Autologous Anti-BCMA CAR-T Cells UF-KURE-BCMA;

NCIt definition : A preparation of autologous CD4 and CD8 T-lymphocytes that have been transduced with a lentiviral vector (LV) encoding for a chimeric antigen receptor (CAR) specific for human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-BCMA CAR T-cells UF-KURE-BCMA specifically recognize and induce selective toxicity in BCMA-expressing tumor cells. BCMA, a tumor specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) and plays a key role in plasma cell survival. BCMA is found on the surfaces of plasma cells and overexpressed on malignant plasma cells.;

Molecule name : UF-KURE-BCMA;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.